Results 131 to 140 of about 16,846 (200)

P1052: IMPACT OF SF3B1 MUTATION IN MYELOFIBROSIS

open access: yesHemaSphere, 2022
J. Senapati   +9 more
openaire   +2 more sources

CO36 | TGF-β pathway deregulation in SF3B1-mutated low risk myelodysplastic syndrome patients

open access: yesHaematologica
Introduction. Myelodysplastic syndromes (MDS) associated with mutations in genes belonging to the splicing machinery, such as SF3B1, SRSF2, U2AF1 and ZRSR2, are characterized by inefficient hematopoiesis and variable risk of evolving into AML. Mutations
Eleonora Lumia
doaj  

U2AF2 controls alternative splicing in speckle-proximal regions in an RS domain-dependent manner. [PDF]

open access: yesNucleic Acids Res
Pankivskyi S   +5 more
europepmc   +1 more source

Serendipity: Decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia [PDF]

open access: yes, 2019
Abboud, Camille N   +7 more
core   +3 more sources

SF3B1K700E mutation in human embryonic stem cells causes aberrant expression of immune-related genes. [PDF]

open access: yesPLoS One
Dastpak M   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy